Evaluation of Positive Inotropic Activity Induced bya Danazol Derivative in Isolated Rat Heart Model
article
OA: hybrid
CC0
⤵ 1 in-corpus citation
AI-generated summary
A synthesized danazol derivative increased perfusion pressure, coronary resistance, and left ventricular pressure in isolated rat hearts, primarily via androgen receptor activation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
There is scarce information about the effects of danazol and its derivatives at cardiovascular level. In addition, to date the cellular site and mechanism of action of danazol at the cardiovascular level is very confusing. In order to clarify those phenomena in this study, a danazol derivative was synthesized with the objective of evaluating its activity on perfusion pressure and coronary resistance and comparing this phenomenon with the effect exerted by danazol. The Langendorff technique was used to measure changes on perfusion pressure and coronary resistance in an isolated rat heart model in the absence or presence of danazol and its derivative. Additionally, to characterize the molecular mechanism involved in the inotropic activity induced by danazol derivative was evaluated by measuring left ventricular pressure in the absence or presence of following compounds; flutamide, prazosin, metoprolol, indomethacin and nifedipine. The results showed that danazol derivative significantly increased the perfusion pressure and coronary resistance in comparison with the control conditions and danazol. Additionally, other data indicate that the danazol derivative increases left ventricular pressure in a dose-dependent manner; nevertheless, this phenomenon was significantly inhibited by flutamide. These data suggest that danazol derivative induces positive inotropic activity through of the activation androgen receptor.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
- Danazol 2022
References (36)
- Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex via openalex
- doi:10.1016/s0040-4039(03)01466-7 via openalex
- doi:10.1021/jm00391a038 via openalex
- doi:10.1016/s0040-4039(03)00436-2 via openalex
- doi:10.1590/s0120-41572011000200011 via openalex
- doi:10.1016/j.catcom.2004.06.007 via openalex
- doi:10.1016/s0022-3565(25)30914-6 via openalex
- doi:10.1210/jc.2002-021072 via openalex
- doi:10.1161/01.hyp.34.4.920 via openalex
- doi:10.3998/ark.5550190.0008.106 via openalex
- doi:10.1093/oxfordjournals.eurheartj.a059571 via openalex
- doi:10.1021/jo00834a087 via openalex
- doi:10.1038/sj.bjp.0706673 via openalex
- doi:10.1021/jm030830y via openalex
- doi:10.5507/bp.2011.018 via openalex
- doi:10.1016/s0031-6997(25)00068-7 via openalex
- doi:10.1161/01.res.15.4.355 via openalex
- doi:10.1016/0090-6980(83)90069-2 via openalex
- W2100135608 via openalex
- doi:10.1210/en.2005-0263 via openalex
- W2469111179 via openalex
- doi:10.1016/s0039-128x(02)00011-9 via openalex
- doi:10.1016/s0735-1097(00)00613-6 via openalex
- doi:10.1021/jm0109208 via openalex
- doi:10.1002/cpt1975174400 via openalex
- doi:10.1097/00000539-200001000-00003 via openalex
- doi:10.1095/biolreprod.106.051813 via openalex
- doi:10.3181/00379727-149-38916 via openalex
- doi:10.1016/0002-9149(80)90366-5 via openalex
- doi:10.1016/s0006-8993(00)03155-3 via openalex
- doi:10.1016/0735-1097(93)90441-3 via openalex
- doi:10.1085/jgp.83.3.395 via openalex
- doi:10.1172/jci15704 via openalex
- doi:10.1016/0303-7207(86)90132-2 via openalex
- doi:10.1001/archsurg.137.10.1180 via openalex
- doi:10.1161/01.cir.102.suppl_4.iv-14 via openalex
Cited by (1)
- Danazol 2022
Source provenance
- openalex
- last seen: 2026-05-11T04:57:32.809404+00:00
License: CC0
· commercial use OK